Your email has been successfully added to our mailing list.

×
0 0 0 0 -0.00719424460431655 -0.00719424460431655 -0.00719424460431655 -0.00719424460431655
Stock impact report

Boston Therapeutics inks Sugardown distribution deal in Asia [Seeking Alpha]

CTI BioPharma Corp. (CTIC) 
Last cti biopharma corp. earnings: 11/1 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ctibiopharma.com
Company Research Source: Seeking Alpha
Boston Therapeutics ( OTCQB:BTHE ) has entered into a co-marketing agreement with China Hiking Group's Jin Long Health for the promotion of Sugardown chewable tablets in China. Financial terms are not disclosed. The stock is down but only on turnover of 500 shares. See all stocks on the move » Now read: CTI BioPharma to cut half of workforce in restructuring; shares down 5% » Subscribe for full text news in your inbox Show less Read more
Impact Snapshot
Event Time:
CTIC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CTIC alerts
Opt-in for
CTIC alerts

from News Quantified
Opt-in for
CTIC alerts

from News Quantified